Aptagen, LLC
GBN2 (ID# 8110)
DNA
Nervous necrosis virus (NNV)
Other
27.96 nM (reported value)
5 g/L glucose,10% FBS, 1.0 g/L bovine serum albumin, 0.1 mg/ml yeast tRNA and 5 mM MgCl2
4°C
NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.
5’-dGpdApdCpdGpdCpdTpdTpdApdCpdTpdCpdApdGpdGpdTpdGpdTpdGpdApdCpdTpdCpdGpdCpdTpdCpdCpdApdCpdTpdGpdGpdTpdCpdCpdGpdGpdApdTpdCpdApdCpdTpdTpdGpdApdTpdApdTpdGpdTpdCpdGpdTpdGpdCpdGpdGpdCpdApdGpdTpdCpdGpdTpdTpdTpdApdCpdApdTpdCpdCpdCpdGpdApdApdGpdGpdApdCpdGpdCpdApdGpdApdTpdGpdApdApdGpdTpdCpdTpdCp-3’
95
29267.9
894300
Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Zhou L, Wang S, Yu Q, et al. Characterization of Novel Aptamers Specifically Directed to Red-Spotted Grouper Nervous Necrosis Virus (RGNNV)-Infected Cells for Mediating Targeted siRNA Delivery. Front Microbiol. 2020;11:660. Published 2020 Apr 30. doi:10.3389/fmicb.2020.00660
Have your aptamer oligo synthesized ORDER
We are always looking for ways to improve. Please tell us what you think.